Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Cancer of the gingiva.

Bark R, Mercke C, Munck-Wikland E, Wisniewski NA, Hammarstedt-Nordenvall L.

Eur Arch Otorhinolaryngol. 2016 Jun;273(6):1335-45. doi: 10.1007/s00405-015-3516-x. Epub 2015 Feb 4. Review.

PMID:
25649283
2.

Compromised quality of life in adult patients who have received a radiation dose towards the basal part of the brain. A case-control study in long-term survivors from cancer in the head and neck region.

Löfdahl E, Berg G, Johansson KA, Zachrisson ML, Malmgren H, Mercke C, Olsson E, Wiren L, Johannsson G.

Radiat Oncol. 2012 Oct 29;7:179. doi: 10.1186/1748-717X-7-179.

3.

Two-year results from a Swedish study on conventional versus accelerated radiotherapy in head and neck squamous cell carcinoma--the ARTSCAN study.

Zackrisson B, Nilsson P, Kjellén E, Johansson KA, Modig H, Brun E, Nyman J, Friesland S, Reizenstein J, Sjödin H, Ekberg L, Lödén B, Mercke C, Fernberg JO, Franzén L, Ask A, Persson E, Wickart-Johansson G, Lewin F, Wittgren L, Björ O, Björk-Eriksson T.

Radiother Oncol. 2011 Jul;100(1):41-8. doi: 10.1016/j.radonc.2010.12.010. Epub 2011 Feb 3.

PMID:
21295880
4.

Expression modes and clinical manifestations of latent membrane protein 1, Ki-67, cyclin-B1, and epidermal growth factor receptor in nonendemic nasopharyngeal carcinoma.

Taheri-Kadkhoda Z, Magnusson B, Svensson M, Mercke C, Björk-Eriksson T.

Head Neck. 2009 Apr;31(4):482-92. doi: 10.1002/hed.21002.

PMID:
19132724
5.

Comparison of predicted and clinical response to radiotherapy: a radiobiology modelling study.

Hedman M, Bjork-Eriksson T, Mercke C, West C, Hesselius P, Brodin O.

Acta Oncol. 2009;48(4):584-90. doi: 10.1080/02841860802637757.

PMID:
19107620
6.

The quality assurance process for the ARTSCAN head and neck study - a practical interactive approach for QA in 3DCRT and IMRT.

Johansson KA, Nilsson P, Zackrisson B, Ohlson B, Kjellén E, Mercke C, Alvarez-Fonseca M, Billström A, Björk-Eriksson T, Björ O, Ekberg L, Friesland S, Karlsson M, Lagerlund M, Lundkvist L, Löfroth PO, Löfvander-Thapper K, Nilsson A, Nyman J, Persson E, Reizenstein J, Rosenbrand HO, Wiklund F, Wittgren L.

Radiother Oncol. 2008 May;87(2):290-9. doi: 10.1016/j.radonc.2007.12.005. Epub 2008 Feb 21.

PMID:
18206256
7.

Long-term treatment results for nasopharyngeal carcinoma: the Sahlgrenska University Hospital experience.

Taheri-Kadkhoda Z, Björk-Eriksson T, Johansson KA, Mercke C.

Acta Oncol. 2007;46(6):817-27.

PMID:
17653906
8.
9.

Accelerated radiotherapy for advanced laryngeal cancer.

Haugen H, Johansson KA, Ejnell H, Edström S, Mercke C.

Acta Oncol. 2005;44(5):481-9.

PMID:
16118082
10.

The biological effect of pentoxifylline on the survival of human head and neck cancer cells treated with continuous low and high dose-rate irradiation.

Danielsson A, Karlsson E, Delle U, Helou K, Mercke C.

J Cancer Res Clin Oncol. 2005 Jul;131(7):459-67. Epub 2005 Mar 18.

PMID:
15776273
11.

Long-term outcome of high dose rate brachytherapy in radiotherapy of localised prostate cancer.

Aström L, Pedersen D, Mercke C, Holmäng S, Johansson KA.

Radiother Oncol. 2005 Feb;74(2):157-61. Epub 2004 Nov 25.

PMID:
15734203
12.

Functional long-term outcome of a free jejunal transplant reconstruction following chemoradiotherapy and radical resection for hypopharyngeal and proximal oesophageal carcinoma.

Bergquist H, Ejnell H, Fogdestam I, Mark H, Mercke C, Lundell L, Ruth M.

Dig Surg. 2004;21(5-6):426-31; discussion 432-3. Epub 2004 Dec 20.

PMID:
15627773
14.

A systematic overview of radiation therapy effects in head and neck cancer.

Zackrisson B, Mercke C, Strander H, Wennerberg J, Cavallin-Ståhl E.

Acta Oncol. 2003;42(5-6):443-61. Review.

PMID:
14596506
15.

Systematic set-up errors for IMRT in the head and neck region: effect on dose distribution.

Samuelsson A, Mercke C, Johansson KA.

Radiother Oncol. 2003 Mar;66(3):303-11.

PMID:
12742270
16.

Hyperfractionated-accelerated or conventionally fractionated radiotherapy for early glottic cancer.

Haugen H, Johansson KA, Mercke C.

Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):109-19.

PMID:
11777628
17.

Accuracy of tele-oncology compared with face-to-face consultation in head and neck cancer case conferences.

Stalfors J, Edström S, Björk-Eriksson T, Mercke C, Nyman J, Westin T.

J Telemed Telecare. 2001;7(6):338-43.

PMID:
11747635
18.

MRI staging using gadodiamide for soft-tissue tumors of the head and neck region. Results from a phase II trial and a 5-year clinical follow-up.

Ekholm SE, Björk-Eriksson T, Western A, Nellström H, Jonsson E, Johansson A, Lönn L, Mercke C, Tollesson PO.

Eur J Radiol. 2001 Sep;39(3):168-75.

PMID:
11566244
19.
20.

Tumor radiosensitivity (SF2) is a prognostic factor for local control in head and neck cancers.

Björk-Eriksson T, West C, Karlsson E, Mercke C.

Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):13-9.

PMID:
10656366
21.

The immunohistochemical expression of DNA-PKCS and Ku (p70/p80) in head and neck cancers: relationships with radiosensitivity.

Björk-Eriksson T, West C, Nilsson A, Magnusson B, Svensson M, Karlsson E, Slevin N, Lewensohn R, Mercke C.

Int J Radiat Oncol Biol Phys. 1999 Nov 1;45(4):1005-10.

PMID:
10571209
22.

Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial.

Westman G, Bergman B, Albertsson M, Kadar L, Gustavsson G, Thaning L, Andersson M, Straumits A, Jeppson B, Lindén CJ, Ewers SB, Andersson H, Mercke C, Hafström L, Birck O, Orgum P.

Eur J Cancer. 1999 Apr;35(4):586-95.

PMID:
10492632
23.

The lack of correlation between proliferation (Ki-67, PCNA, LI, Tpot), p53 expression and radiosensitivity for head and neck cancers.

Björk-Eriksson T, West CM, Cvetskovska E, Svensson M, Karlsson E, Magnusson B, Slevin NJ, Edström S, Mercke C.

Br J Cancer. 1999 Jul;80(9):1400-4.

24.

Discrimination of human tumor radioresponsiveness using low-dose rate irradiation.

Björk-Eriksson T, West C, Karlsson E, Mercke C.

Int J Radiat Oncol Biol Phys. 1998 Dec 1;42(5):1147-53.

PMID:
9869242
26.

Malnutrition and food intake in relation to quality of life in head and neck cancer patients.

Hammerlid E, Wirblad B, Sandin C, Mercke C, Edström S, Kaasa S, Sullivan M, Westin T.

Head Neck. 1998 Sep;20(6):540-8.

PMID:
9702542
27.

The in vitro radiosensitivity of human head and neck cancers.

Björk-Eriksson T, West CM, Karlsson E, Slevin NJ, Davidson SE, James RD, Mercke C.

Br J Cancer. 1998 Jun;77(12):2371-5.

28.
30.

Combined treatment with temporary short-term high dose rate iridium-192 brachytherapy and external beam radiotherapy for irradiation of localized prostatic carcinoma.

Borghede G, Hedelin H, Holmäng S, Johansson KA, Aldenborg F, Pettersson S, Sernbo G, Wallgren A, Mercke C.

Radiother Oncol. 1997 Sep;44(3):237-44.

PMID:
9380822
31.
32.

Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized phase III study.

Lewin F, Damber L, Jonsson H, Andersson T, Berthelsen A, Biörklund A, Blomqvist E, Evensen JF, Hansen HS, Hansen O, Jetlund O, Mercke C, Modig H, Overgaard M, Rosengren B, Tausjö J, Ringborg U.

Radiother Oncol. 1997 Apr;43(1):23-8.

PMID:
9165133
33.
34.

Advanced laryngeal cancer T3-T4 in Sweden: a retrospective study 1986-1990. Survival and locoregional control related to treatment.

Finizia C, Geterud A, Holmberg E, Lindström J, Lundgren J, Kuylenstierna R, Rylander R, Biörklund A, Rydell R, Andréason L, Mercke C.

Acta Otolaryngol. 1996 Nov;116(6):906-12.

PMID:
8973731
35.

Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. The Swedish Lung Cancer Study Group.

Brodin O, Nou E, Mercke C, Lindén CJ, Lundström R, Arwidi A, Brink J, Ringborg U.

Eur J Cancer. 1996 Oct;32A(11):1893-900.

PMID:
8943671
38.

Primary radiotherapy for glottic laryngeal carcinoma stage I and II. A retrospective study with special regard to failure patterns.

Turesson I, Sandberg N, Mercke C, Johansson KA, Sandin I, Wallgren A.

Acta Oncol. 1991;30(3):357-62.

PMID:
2036247
39.

Induction chemotherapy (cisplatin + 5-fluorouracil) and radiotherapy in advanced squamous cell carcinoma of the head and neck.

Tennvall J, Albertsson M, Biörklund A, Wennerberg J, Anderson H, Andersson T, Elner A, Mercke C.

Acta Oncol. 1991;30(1):27-32.

PMID:
2009181
40.

Cisplatin and 5-FU combined with radiotherapy and surgery in the treatment of squamous cell carcinoma of the esophagus. Palliative effects and tumor response.

Mercke C, Albertsson M, Hambraeus G, Tennvall J, Lillo-Gil R, Samuelsson L, Willén R, Ranstam J.

Acta Oncol. 1991;30(5):617-22.

PMID:
1716448
41.
42.

[Pain relief in terminal care].

Wallgren A, Mercke C.

Lakartidningen. 1989 May 24;86(21):1975. Swedish. No abstract available.

PMID:
2471905
43.
44.

Adverse cardiac effects during induction chemotherapy treatment with cis-platin and 5-fluorouracil.

Eskilsson J, Albertsson M, Mercke C.

Radiother Oncol. 1988 Sep;13(1):41-6.

PMID:
3187073
46.

Effects of fractionated irradiation on the esophageal mucosa: a scanning and transmission electron microscopic study.

Albertsson M, Hakansson CH, Mercke C, Morner H.

Scanning Microsc. 1987 Dec;1(4):1851-60.

PMID:
3433066
47.

Intra-arterial mitomycin C and intravenous bleomycin as induction chemotherapy in advanced head and neck cancer--a phase II study.

Andreasson L, Biörklund A, Mercke C, Scheike O, Andersson T, Brismar J, Elner A, Hellekant C, Landberg T, Tropé C.

Radiother Oncol. 1986 Sep;7(1):37-45.

PMID:
2430316
48.
49.

Electrolytic tissue destruction and external beam irradiation of the lung. An experimental and clinical investigation.

Samuelsson L, Lamm IL, Mercke CE, Ståhl E, Jönsson L.

Acta Radiol Diagn (Stockh). 1985 Sep-Oct;26(5):521-4.

PMID:
4072745
50.

Supplemental Content

Loading ...
Support Center